Skin As A Reflection Of Hepatitis C Virus Infection And Adverse Effects Of Its Treatment

K. Jasleen, Kalsy Jyotika
{"title":"Skin As A Reflection Of Hepatitis C Virus Infection And Adverse Effects Of Its Treatment","authors":"K. Jasleen, Kalsy Jyotika","doi":"10.5580/2acc","DOIUrl":null,"url":null,"abstract":"Sir, Hepatitis C viral infection (HCV) is a major global health concern with 170 million people affected worldwide there are estimated 12 -13 million carriers in India presently 1 . Currently the combination of peg interferon and ribavarin is considered the standard treatment of HCV infection 2 . Although combination of these two drugs is most effective but it is also associated with increased risk of side effects due to immunomodulatory effect of both the drugs 3 . Dermatological side effects in the form of skin rashes, dryness, pruritus, pyoderma gangrenosum, alopecia, toxic epidermal necrolysis, new or exacerbation of psoriasis, induration and ulceration at the injection site can occur 4 . On the other hand various skin disorders such as lichen planus, necrotising vasculitis or porphyria cutanea tarda are more commonly associated with hepatitis C infection 5 . We as dermatologist are referred cases with cutaneous manifestations from various specialties and should be aware whether these changes are due to disease itself or its treatment. We observed 30 HCV positive and HIV negative cases with dermatological manifestations (Table-1) on combination treatment with Ribavarin and peginterferon who came to our OPD over a period of two years for skin opinion. Out of those 30 cases, 28 patients were males and only 2 were females. They were in the age range 35 to 55 years. All of them were on a regimen of peginterferon","PeriodicalId":161194,"journal":{"name":"The Internet Journal of Dermatology","volume":"51 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Internet Journal of Dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5580/2acc","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Sir, Hepatitis C viral infection (HCV) is a major global health concern with 170 million people affected worldwide there are estimated 12 -13 million carriers in India presently 1 . Currently the combination of peg interferon and ribavarin is considered the standard treatment of HCV infection 2 . Although combination of these two drugs is most effective but it is also associated with increased risk of side effects due to immunomodulatory effect of both the drugs 3 . Dermatological side effects in the form of skin rashes, dryness, pruritus, pyoderma gangrenosum, alopecia, toxic epidermal necrolysis, new or exacerbation of psoriasis, induration and ulceration at the injection site can occur 4 . On the other hand various skin disorders such as lichen planus, necrotising vasculitis or porphyria cutanea tarda are more commonly associated with hepatitis C infection 5 . We as dermatologist are referred cases with cutaneous manifestations from various specialties and should be aware whether these changes are due to disease itself or its treatment. We observed 30 HCV positive and HIV negative cases with dermatological manifestations (Table-1) on combination treatment with Ribavarin and peginterferon who came to our OPD over a period of two years for skin opinion. Out of those 30 cases, 28 patients were males and only 2 were females. They were in the age range 35 to 55 years. All of them were on a regimen of peginterferon
皮肤作为丙型肝炎病毒感染的反映及其治疗的不良反应
先生,丙型肝炎病毒感染(HCV)是全球主要的健康问题,全世界有1.7亿人受到影响,目前印度估计有1200万至1300万携带者。目前聚乙二醇干扰素联合利巴伐林被认为是HCV感染的标准治疗方案2。虽然这两种药物联合使用是最有效的,但由于两种药物的免疫调节作用,副作用的风险也增加了。可出现皮疹、干燥、瘙痒、坏疽性脓皮病、脱发、中毒性表皮坏死松解、牛皮癣新发或加重、注射部位硬化和溃疡等皮肤病副作用。另一方面,各种皮肤疾病,如扁平苔藓、坏死性血管炎或迟发性皮肤卟啉症,更常与丙型肝炎感染有关。作为皮肤科医生,我们有来自不同专业的皮肤表现的转诊病例,应该意识到这些变化是由于疾病本身还是其治疗。我们观察了30例HCV阳性和HIV阴性的皮肤病学表现(表1),联合利巴伐林和聚乙二醇干扰素治疗,在两年内来我们的OPD咨询皮肤意见。30例患者中,男性28例,女性2例。他们的年龄在35到55岁之间。所有患者都服用聚乙二醇干扰素
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信